UC Irvine neuroscientists Frank LaFerla and Mathew Blurton-Jones (pictured) were awarded $3.6 million April 29 toward the development of an Alzheimer’s disease therapy involving human neural stem cells. LaFerla, director of the UCI Institute for Brain Aging and Dementia, and Blurton-Jones will use the California Institute for Regenerative Medicine grant to test in mice whether human stem cells can reverse dementia caused by Alzheimer’s. The project builds on their previous work showing that mouse neural stem cells can restore memory in mice with brain damage.